Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 140 blog entries.

MHRA Class 3 Medicines Recall: Fluenz® Tetra nasal spray suspension (AstraZeneca UK Ltd)

Drug alert number: EL (23)A/39 Date issued: 30 November 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Fluenz® Tetra nasal spray suspension PLGB 17901/034 SNOMED Code: 27114211000001105 Batch Number Printed Expiry Date Amended Expiry Date Pack Size First Distributed TH2127 28-Dec-23 23-Dec-23 10 sprayers 30-Aug-23 TH2127B [...]

The post MHRA Class 3 Medicines Recall: Fluenz® Tetra nasal spray suspension (AstraZeneca UK Ltd) appeared first on Community Pharmacy England.

By |November 30th, 2023|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Fluenz® Tetra nasal spray suspension (AstraZeneca UK Ltd)

MHRA Medical Device Recall: Aacarb® eye gel, Aacomer® eye gel and Puroptics® eye gel (Carbomer eye gel)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a medical device recall for: AACARB® eye gel, AACOMER® eye gel and PUROPTICS® eye gel (Carbomer eye gel) Device Name: AACARB eye gel, AACOMER eye gel and PUROPTICS eye gel Distributed After: August 2023 Product code: CB048G1H Affected lot numbers/serial numbers: 3H02, 3H03, 3H04, 3H05, 3H06, 3H07, 3H08, 3H09, [...]

The post MHRA Medical Device Recall: Aacarb® eye gel, Aacomer® eye gel and Puroptics® eye gel (Carbomer eye gel) appeared first on Community Pharmacy England.

By |November 27th, 2023|Lexpos News|Comments Off on MHRA Medical Device Recall: Aacarb® eye gel, Aacomer® eye gel and Puroptics® eye gel (Carbomer eye gel)

MHRA Drug Safety Update: November 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 4 November 2023) has been published and includes articles on: Ozempic▼(semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products Nirmatrelvir, ritonavir (Paxlovid▼): be alert to the risk of drug interactions with ritonavir E-cigarette use or vaping: reminder [...]

The post MHRA Drug Safety Update: November 2023 appeared first on Community Pharmacy England.

By |November 23rd, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update: November 2023

Expiry of SSP054 Clarithromycin 250mg/5ml oral suspension

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 250mg/5ml oral suspension are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP054 Clarithromycin 250mg/5ml oral suspension at 23.59pm on Friday 17 November 2023. After this date, any prescriptions for Clarithromycin 250mg/5ml oral suspension must be [...]

The post Expiry of SSP054 Clarithromycin 250mg/5ml oral suspension appeared first on Community Pharmacy England.

By |November 17th, 2023|Lexpos News|Comments Off on Expiry of SSP054 Clarithromycin 250mg/5ml oral suspension

Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension – Updated

Updated 12th February 2024 – updates are shown in bold below: Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension  MSN/2023/103U Tier 3 – high impact  Date of issue 17th November 2023 (updated 12th February 2024) Co-trimoxazole 40mg/200mg/5ml oral [...]

The post Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension – Updated appeared first on Community Pharmacy England.

By |November 7th, 2023|Lexpos News|Comments Off on Medicine Supply Notification: Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension – Updated